Biocryst Pharmaceuticals Inc (BCRX)
EBITDA Growth
-577.55%
TTM · Period ending:
BCRX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-577.55%period ending
Latest reported-577.55%period ending
BCRX TTM EBITDA YoY % (-31.25% → -577.55%)
Year-over-year change
High-resolution chart · PNG
BCRX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 4.5617% | |
| -55.7007% | |
| -51.749% | |
| -24.8299% | |
| -388.522% | |
| -63.6444% | |
| -44.3654% | |
| -1.5735% | |
| 83.9664% | |
| 60.177% | |
| 55.1724% | |
| 33.9806% | |
| -19% | |
| -28.4091% | |
| -61.1111% | |
| -41.0959% | |
| -42.8571% | |
| -17.3333% | |
| 14.2857% | |
| 9.8765% | |
| 7.8947% | |
| 3.8462% | |
| -31.25% |